isoxazoles and thromboxane a2
isoxazoles has been researched along with thromboxane a2 in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Demina, OV; Shram, SI; Varfolomeev, SD; Vrzheshch, PV | 1 |
Fujita, H; Morita, I; Sato, T; Tanaka, N | 1 |
Fitzgerald, GA | 1 |
Bernstein, SH; Chiorazzi, N; Felgar, RE; Kaur, K; Phipps, RP; Pollock, SJ; Ryan, EP | 1 |
Dogné, JM; Hanson, J; Pratico, D; Supuran, C | 1 |
Araujo, M; Welch, WJ | 1 |
Bruno, A; Dovizio, M; Lavecchia, A; Malerba, P; Marcantoni, E; Patrignani, P; Perrone, MG; Scilimati, A; Simone, L; Tacconelli, S; Vitale, P | 1 |
Reviews
1 review(s) available for isoxazoles and thromboxane a2
Article | Year |
---|---|
Coxibs and cardiovascular side-effects: from light to shadow.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Epoprostenol; Humans; Isoxazoles; Lactones; Pyrazoles; Structure-Activity Relationship; Sulfonamides; Sulfones; Thromboxane A2 | 2006 |
Other Studies
6 other study(ies) available for isoxazoles and thromboxane a2
Article | Year |
---|---|
Supercooperativity in platelet aggregation: substituted pyridyl isoxazoles, a new class of supercooperative platelet aggregation inhibitors.
Topics: Allosteric Regulation; Arachidonic Acid; Bicyclic Monoterpenes; Dose-Response Relationship, Drug; Humans; Indomethacin; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Thromboxane A2 | 1994 |
Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis.
Topics: Cell Differentiation; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Induction; Fetal Blood; Hematopoietic Stem Cells; Humans; Infant, Newborn; Isoenzymes; Isoxazoles; Megakaryocytes; Membrane Proteins; Nitrobenzenes; Platelet Count; Pluripotent Stem Cells; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Stem Cell Factor; Sulfonamides; Thrombopoiesis; Thrombopoietin; Thromboxane A2 | 2004 |
Coxibs and cardiovascular disease.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Approval; Drug Industry; Epoprostenol; Gastrointestinal Diseases; Humans; Isoenzymes; Isoxazoles; Lactones; Membrane Proteins; Naproxen; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Risk; Sulfonamides; Sulfones; Thromboxane A2; United States; United States Food and Drug Administration | 2004 |
Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells.
Topics: B-Lymphocytes; Cell Growth Processes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprost; Dinoprostone; Enzyme Activation; Humans; Immunoglobulin Heavy Chains; Immunohistochemistry; Indomethacin; Isoxazoles; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrobenzenes; Pyrazoles; Sulfonamides; Sulfones; Thromboxane A2 | 2006 |
Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide.
Topics: Animals; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Fatty Acids, Unsaturated; Feedback, Physiological; Hydrazines; Isoxazoles; Kidney Glomerulus; Kidney Tubules; Male; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction | 2009 |
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
Topics: Animals; Blood Platelets; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Fibrinolytic Agents; Furans; Humans; Isoxazoles; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Structure-Activity Relationship; Thromboxane A2 | 2013 |